[go: up one dir, main page]

AR008306A1 - Uso de amoxicilina y clavulanato en la fabricacion de un medicamento - Google Patents

Uso de amoxicilina y clavulanato en la fabricacion de un medicamento

Info

Publication number
AR008306A1
AR008306A1 ARP970103808A ARP970103808A AR008306A1 AR 008306 A1 AR008306 A1 AR 008306A1 AR P970103808 A ARP970103808 A AR P970103808A AR P970103808 A ARP970103808 A AR P970103808A AR 008306 A1 AR008306 A1 AR 008306A1
Authority
AR
Argentina
Prior art keywords
clavulanate
amoxicillin
manufacture
medicinal product
inclusive
Prior art date
Application number
ARP970103808A
Other languages
English (en)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of AR008306A1 publication Critical patent/AR008306A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

El uso de amoxicilina y clavulanato en la fabricación de un medicamento para el tratamiento empírico de infecciones causadas potencialmente porDRSP (Streptococcus pneumoniae resistentes a los fármacos), que comprende, para un paciente adultoo nino mayor, de 800 a 1100 mg de amoxicilina y de 100a 150 mg de clavulanato en una relación en peso entre 6:1 y 10:1 inclusive; o para un paciente pediátrico, de 30 a 40 mg/kg de peso de amoxicilina y de 3 a 8mg/kg de peso de clavulanato en unarelación en peso entre 6:1 y 10:1 inclusive; siendo tomado el medicamento tres veces al día (tid).
ARP970103808A 1996-08-24 1997-08-21 Uso de amoxicilina y clavulanato en la fabricacion de un medicamento AR008306A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9617780.3A GB9617780D0 (en) 1996-08-24 1996-08-24 Method of treatment

Publications (1)

Publication Number Publication Date
AR008306A1 true AR008306A1 (es) 1999-12-29

Family

ID=10798919

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970103808A AR008306A1 (es) 1996-08-24 1997-08-21 Uso de amoxicilina y clavulanato en la fabricacion de un medicamento

Country Status (20)

Country Link
US (2) US6214359B1 (es)
EP (1) EP0938312A1 (es)
JP (1) JP2000516243A (es)
KR (1) KR20000068329A (es)
CN (1) CN1233958A (es)
AR (1) AR008306A1 (es)
AU (1) AU722657B2 (es)
BR (1) BR9711642A (es)
CA (1) CA2264074A1 (es)
CO (1) CO5021201A1 (es)
CZ (1) CZ59299A3 (es)
GB (1) GB9617780D0 (es)
HU (1) HUP0201440A3 (es)
IL (1) IL128644A0 (es)
NO (1) NO990845L (es)
NZ (1) NZ334345A (es)
PL (1) PL331764A1 (es)
TR (1) TR199900413T2 (es)
WO (1) WO1998007424A1 (es)
ZA (1) ZA977564B (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030109503A1 (en) * 1995-06-06 2003-06-12 Smithkline Beecham P.L.C. Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
US6294199B1 (en) * 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6565882B2 (en) * 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
EP1330236A2 (en) 2000-10-12 2003-07-30 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US6541014B2 (en) * 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US20020197314A1 (en) * 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
KR20050005437A (ko) * 2002-04-09 2005-01-13 플라멜 테크놀로지스 아목시실린의 변형 방출을 위한 마이크로캡슐 수성 현탁액형태의 경구 제약학적 제제
KR100456833B1 (ko) * 2002-08-01 2004-11-10 주식회사 대웅 아목시실린 및 클라불라네이트를 함유하는 유핵정
JP2006528185A (ja) * 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
AU2004258953B2 (en) * 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
AU2004258949B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
JP2007502296A (ja) * 2003-08-11 2007-02-08 アドバンシス ファーマスーティカル コーポレイション ロバストペレット
EP1653924A4 (en) * 2003-08-12 2009-09-09 Middlebrook Pharmaceuticals In ANTIBIOTICS, USE AND FORMULATION ASSOCIATED
CA2535780A1 (en) 2003-08-29 2005-03-17 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
CA2538064C (en) * 2003-09-15 2013-12-17 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
EP1701705A4 (en) * 2003-12-24 2007-08-08 Advancis Pharmaceutical Corp IMPROVED ABSORPTION OF DOSAGE FORMS WITH MODIFIED RELEASE
JP2008505124A (ja) * 2004-07-02 2008-02-21 アドバンシス ファーマスーティカル コーポレイション パルス送達用錠剤
US8778924B2 (en) * 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
US9034410B2 (en) * 2011-08-22 2015-05-19 Thomas J. Vella Whole green coffee bean products and methods of production and use
WO2013173803A2 (en) * 2012-05-17 2013-11-21 Michael Spector Formulations of amoxicillin and clavulanate potassium and methods for using same
WO2013173808A2 (en) * 2012-05-17 2013-11-21 Michael Spector Methods for use of lower dose compositions of amoxicillin and clavulanate potassium and devices for use
JP7629693B2 (ja) 2020-04-28 2025-02-14 小林製薬株式会社 抗菌剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
US5753434A (en) 1995-02-10 1998-05-19 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for altering sexual behavior
DZ2028A1 (fr) * 1995-05-03 2002-10-23 Smithkline Beecham Plc Médicaments destinés au traitement d'infections bactériennes en pédiatrie.
ES2165997T3 (es) * 1995-09-07 2002-04-01 Smithkline Beecham Plc Uso de una formulacion farmaceutica pediatrica que comprende amoxicilina y clavulanato.

Also Published As

Publication number Publication date
ZA977564B (en) 1999-02-22
KR20000068329A (ko) 2000-11-25
TR199900413T2 (xx) 1999-06-21
JP2000516243A (ja) 2000-12-05
US6214359B1 (en) 2001-04-10
CN1233958A (zh) 1999-11-03
CA2264074A1 (en) 1998-02-26
NO990845D0 (no) 1999-02-23
NO990845L (no) 1999-04-19
NZ334345A (en) 2000-10-27
AU4022697A (en) 1998-03-06
AU722657B2 (en) 2000-08-10
BR9711642A (pt) 2000-10-24
HUP0201440A3 (en) 2003-04-28
EP0938312A1 (en) 1999-09-01
PL331764A1 (en) 1999-08-02
IL128644A0 (en) 2000-01-31
WO1998007424A1 (en) 1998-02-26
GB9617780D0 (en) 1996-10-02
CZ59299A3 (cs) 1999-08-11
CO5021201A1 (es) 2001-03-27
US20020114842A1 (en) 2002-08-22
HUP0201440A2 (en) 2002-09-28

Similar Documents

Publication Publication Date Title
AR008306A1 (es) Uso de amoxicilina y clavulanato en la fabricacion de un medicamento
AR004510A1 (es) Composiciones que comprenden amoxicilina y clavulanato, procedimientos para su preparacion y el uso de las composiciones para la fabricacion de unmedicamento
CO5170471A1 (es) Tabletas de liberacion modificada que incluyen amoxilina y clavulanato de potasio
EP1243267A3 (en) Amoxycillin and clavulanate containing pharmaceutical formulation
ES2189803T3 (es) Procedimiento.
AR004700A1 (es) 1alfa, 26 dihidroxi-d-homo-vitamina d3, una composicion farmaceutica que la comprende, un procedimiento para su preparacion y el uso de los mismos en laelaboracion de un medicamento
ES2062392T3 (es) Medicamentos que comprenden salmeterol y fluticasona.
DE69520882D1 (de) Arzneizubereitung enthaltend amoxycillin und kaliumclavunalat
AR020001A1 (es) COMPUESTOS ACTIVADORES DE hPPARGAMMA Y hPPARALFA, COMPOSICIONES FARMACEUTICAS QUE LOS COMPRENDEN, METODO PARA EL TRATAMIENTO Y/O PREVENCION DE UNAENFERMEDAD MEDIADA POR LOS MISMOS, Y SU USO PARA LA ELABORACION DE UN MEDICAMENTO
ES2188782T3 (es) Formulaciones farmaceuticas que contienen darifenacina.
ES2152966T3 (es) Formas de dosificado farmaceuticas de desleido rapido y procedimiento para su preparacion.
ES2170069T3 (es) 1-alfa-hidroxiprevitamina d para administracion oral.
ES2145264T3 (es) (2,4-disulfofenil)-n-tert-butilnitrona, sus sales y su utilizacion como agentes captadores de radicales farmaceuticos.
BR9712523A (pt) Novos derivados de pirazol heterociclilmetil-substituìdos
ATE309798T1 (de) Pharmazeutische zusammensetzungen enthaltend cannabidiol-derivate
NO20055880L (no) Memantin orale doseringsformer
ES2037086T3 (es) Procedimiento para preparar formulaciones farmaceuticas.
AU1935788A (en) A process for producing an administration and/or dosage form for medically active ingredients of drugs
ES2160821T3 (es) Uso de una composicion que comprende amoxicilina y acido clavulanico para la produccion de un medicamento para el tratamiento de infecciones bacterianas en pacientes pediatricos.
IT1263840B (it) Formulazioni orali di ubidecarenone in forma di capsule
AR036312A1 (es) Composicion farmaceutica
ES2139842T3 (es) Uso de la melatonina para tratar a pacientes que sufren drogodependencia.
CR6834A (es) Complejos y composiciones de medicamentos macromoleculares que contienen lo mismo
YU36401A (sh) Farmaceutska kompozicija za stimulator osetljivosti na insulin sa modifikovanim ispuštanjem
AR021086A1 (es) Omega-amidas de n-arilsulfonil-aminoacidos, un procedimiento para su preparacion, medicamento, uso de dichos compuestos para la preparacion de un medicamento y procedimiento para la preparacion de un medicamento.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal